These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 16640512)
1. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake. Kristoffersen US; Hesse B; Rasmussen AK; Kjaer A Clin Physiol Funct Imaging; 2006 May; 26(3):167-70. PubMed ID: 16640512 [TBL] [Abstract][Full Text] [Related]
2. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Graves' hyperthyroidism--prognostic factors for outcome. Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701 [TBL] [Abstract][Full Text] [Related]
8. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume]. Seeger T; Emrich D; Sandrock D Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642 [TBL] [Abstract][Full Text] [Related]
9. Radioiodine treatment of feline hyperthyroidism in Germany. Puille M; Knietsch M; Spillmann T; Grünbaum EG; Bauer R Nuklearmedizin; 2002 Dec; 41(6):245-51. PubMed ID: 12520661 [TBL] [Abstract][Full Text] [Related]
10. Thyroid-hormone concentrations after radioiodine therapy for hyperthyroidism. Tamagna EI; Levine GA; Hershman JM J Nucl Med; 1979 May; 20(5):387-91. PubMed ID: 541694 [TBL] [Abstract][Full Text] [Related]
11. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease. Baczyk M; Junik R; Ziemnicka K; Sowiński J Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495 [TBL] [Abstract][Full Text] [Related]
12. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study. Chouhan A; Abhyankar A; Basu S Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804 [TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of 524 cats with hyperthyroidism. Peterson ME; Becker DV J Am Vet Med Assoc; 1995 Dec; 207(11):1422-8. PubMed ID: 7493869 [TBL] [Abstract][Full Text] [Related]
14. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option]. Jiskra J; Kubinyi J; Telička Z Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087 [TBL] [Abstract][Full Text] [Related]
15. [Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)]. Mertz DP; Koch B MMW Munch Med Wochenschr; 1977 Jul; 119(28):945-8. PubMed ID: 408626 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)]. Glanzmann Ch; Horst W Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268 [TBL] [Abstract][Full Text] [Related]
18. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement. Jørgensen HB; Høilund-Carlsen PF; Nielsen VE Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558 [TBL] [Abstract][Full Text] [Related]
19. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment. Wallaschofski H; Müller D; Georgi P; Paschke R Horm Metab Res; 2002 Jan; 34(1):36-9. PubMed ID: 11833000 [TBL] [Abstract][Full Text] [Related]
20. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]